review Open AccessTop 1% cited
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
Annals of Oncology · 2017 · Vol. 28(10) · pp. 2377–2385
Leila Khoja(Addenbrooke's Hospital)Daphne Day(University of Toronto)Tom Wei‐Wu Chen(National Taiwan University Hospital)L.L. Siu(University of Toronto)Aaron R. Hansen✉(Princess Margaret Cancer Centre)
Cancer Immunotherapy and BiomarkersCAR-T cell therapy researchColorectal Cancer Treatments and StudiesMedicineInternal medicineAdverse effectRashNivolumabImmunologyPneumonitisCancerImmunotherapyLung
MeSH terms
Antineoplastic Agents, ImmunologicalAntibodies, MonoclonalClinical Trials as TopicHumansImmune System DiseasesNeoplasmsRandomized Controlled Trials as TopicCTLA-4 AntigenProgrammed Cell Death 1 Receptor
Citations
898
FWCI
28.02
field-weighted impact
References
76
Percentile
100%
vs. same field & year
Citations per year
References
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
The Lancet Oncology · 2015 · 1,554 citations
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
New England Journal of Medicine · 2015 · 9,308 citations
Oncology Meets Immunology: The Cancer-Immunity Cycle
Immunity · 2013 · 6,760 citations
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Journal of Clinical Oncology · 2010 · 2,913 citations
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Journal of Hepatology · 2013 · 982 citations
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
New England Journal of Medicine · 2010 · 15,037 citations
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
New England Journal of Medicine · 2012 · 7,941 citations
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · 9,391 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.